Yangfeng Ding

560 total citations
35 papers, 368 citations indexed

About

Yangfeng Ding is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Yangfeng Ding has authored 35 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 12 papers in Dermatology and 8 papers in Rheumatology. Recurrent topics in Yangfeng Ding's work include Psoriasis: Treatment and Pathogenesis (19 papers), Dermatology and Skin Diseases (12 papers) and Autoimmune Bullous Skin Diseases (7 papers). Yangfeng Ding is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (19 papers), Dermatology and Skin Diseases (12 papers) and Autoimmune Bullous Skin Diseases (7 papers). Yangfeng Ding collaborates with scholars based in China, United States and Hong Kong. Yangfeng Ding's co-authors include Jiajing Lu, Xilin Zhang, Chunyuan Guo, Ning Yu, Rui Ma, Yuling Shi, Weimin Shi, Xin Wang, Lian Cui and Yuling Shi and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Yangfeng Ding

32 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangfeng Ding China 12 166 156 90 69 41 35 368
Qi Tan China 12 76 0.5× 90 0.6× 110 1.2× 52 0.8× 26 0.6× 25 323
Yanhong Shou China 10 108 0.7× 144 0.9× 61 0.7× 98 1.4× 17 0.4× 17 342
Yuzhen Wei China 11 150 0.9× 130 0.8× 23 0.3× 47 0.7× 29 0.7× 14 347
Zhifang Zhai China 14 210 1.3× 97 0.6× 91 1.0× 36 0.5× 82 2.0× 34 414
Eva Santamaría Spain 12 82 0.5× 142 0.9× 27 0.3× 32 0.5× 25 0.6× 29 394
Bingni Chen China 7 245 1.5× 101 0.6× 83 0.9× 11 0.2× 38 0.9× 11 417
Deepak Balak Netherlands 13 241 1.5× 78 0.5× 152 1.7× 13 0.2× 80 2.0× 30 435
Shane E. Russell Ireland 7 175 1.1× 58 0.4× 69 0.8× 15 0.2× 26 0.6× 7 285
Takayuki Kojima Japan 12 91 0.5× 133 0.9× 52 0.6× 33 0.5× 22 0.5× 29 389
Lidia La Barbera Italy 7 152 0.9× 93 0.6× 37 0.4× 13 0.2× 28 0.7× 26 342

Countries citing papers authored by Yangfeng Ding

Since Specialization
Citations

This map shows the geographic impact of Yangfeng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangfeng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangfeng Ding more than expected).

Fields of papers citing papers by Yangfeng Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangfeng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangfeng Ding. The network helps show where Yangfeng Ding may publish in the future.

Co-authorship network of co-authors of Yangfeng Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yangfeng Ding. A scholar is included among the top collaborators of Yangfeng Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangfeng Ding. Yangfeng Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Xiaoying, Ping Xia, Ning Huang, et al.. (2025). A Randomized Controlled Trial for the Optimal Implementation of Psoriasis Treatment by Integrating Chinese and Western Medicine. PubMed. Volume 15. 55–66. 1 indexed citations
2.
Zhang, Yuexin, et al.. (2025). Outcomes and risk factors of COVID-19 in patients with bullous pemphigoid: a cross-sectional study. Frontiers in Immunology. 16. 1568801–1568801.
3.
4.
Zhao, Yan, Litao Zhang, Liming Wu, et al.. (2025). Efficacy and Safety of 611 in Chinese Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Phase II Trial. Dermatology and Therapy. 15(4). 857–867. 1 indexed citations
5.
6.
7.
Zheng, Jianfeng, et al.. (2024). Effectiveness of baricitinib in acquired reactive perforating collagenosis: a case report. Frontiers in Immunology. 15. 2 indexed citations
8.
Huang, Dawei, Zitong Chen, Yingyuan Yu, et al.. (2024). Advantages of ultrasound imaging for the early diagnosis of psoriatic arthritis in patients with moderate to severe psoriasis. Heliyon. 10(13). e34136–e34136.
9.
Hu, Yifan, Dawei Huang, Qian Yu, et al.. (2024). Decreased risk of COVID-19 and long COVID in patients with psoriasis receiving IL-23 inhibitor: A cross-sectional cohort study from China. Heliyon. 10(2). e24096–e24096. 6 indexed citations
10.
Huang, Dawei, Yuexin Zhang, Yingyuan Yu, et al.. (2023). Long-term efficacy and safety of dupilumab for severe bullous pemphigoid: A prospective cohort study. International Immunopharmacology. 125(Pt A). 111157–111157. 13 indexed citations
11.
Lu, Xiya, et al.. (2023). BMP9 functions as a negative regulator in the myogenic differentiation of primary mouse myoblasts. Bioscience Biotechnology and Biochemistry. 87(11). 1255–1264. 7 indexed citations
12.
Zhang, Yuexin, et al.. (2023). Subungual haemorrhage in a patient with pemphigus vulgaris. European Journal of Dermatology. 33(2). 178–179. 1 indexed citations
13.
Yu, Yingyuan, Dawei Huang, Yangfeng Ding, et al.. (2023). Lesion area reduction and the amelioration of anxiety and depression states in psoriasis patients: A prospective clinical study. Journal of Affective Disorders. 344. 335–338. 6 indexed citations
14.
Li, Ying, Jiajing Lu, Yingyuan Yu, et al.. (2022). Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study. Clinical Cosmetic and Investigational Dermatology. Volume 15. 2245–2252. 11 indexed citations
15.
Li, Ying, Yingyuan Yu, Yu Wang, et al.. (2022). Ixekizumab four-week dosing is comparable to two-week dosing in psoriasis patients and reduces treatment costs: experience in a real-world setting over a 12-week period. European Journal of Dermatology. 32(5). 618–622. 3 indexed citations
16.
Zheng, Jianfeng, et al.. (2021). A case of tripterygium glycosides‐associated AGEP ‐like drug reaction combined with bullous pemphigoid. Dermatologic Therapy. 34(4). e15012–e15012. 1 indexed citations
17.
Zhao, Yi, Gang Wang, Zhiqiang Song, et al.. (2021). Visit Adherence of Mild to Moderate Psoriasis Patients: A Mobile-Based Randomized Study. Patient Preference and Adherence. Volume 14. 2551–2557. 3 indexed citations
18.
Gao, Wei, Ying Zou, Yimei Tan, et al.. (2019). The acute effects of ultraviolet radiation exposure on solar dermatitis in Shanghai, China. International Journal of Biometeorology. 64(4). 585–591. 3 indexed citations
19.
Zheng, Jianfeng, et al.. (2018). A Case of Ceftriaxone-Induced Acute Generalized Exanthematous Pustulosis/Generalized Pustular Psoriasis Overlap. Case Reports in Dermatology. 10(1). 69–75. 9 indexed citations
20.
Zhou, Jing, et al.. (2015). Ginsenoside Rh2 Suppresses Neovascularization in Xenograft Psoriasis Model. Cellular Physiology and Biochemistry. 36(3). 980–987. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qi Tan Breakdown of academic impact, for papers by Yanhong Shou Breakdown of academic impact, for papers by Yuzhen Wei Breakdown of academic impact, for papers by Zhifang Zhai Breakdown of academic impact, for papers by Eva Santamaría Breakdown of academic impact, for papers by Bingni Chen Breakdown of academic impact, for papers by Deepak Balak Breakdown of academic impact, for papers by Shane E. Russell Breakdown of academic impact, for papers by Takayuki Kojima Breakdown of academic impact, for papers by Lidia La Barbera
Rankless by CCL
2026